Detection of bacterial contamination in apheresis platelets: Is apheresis technology a factor?

Transfusion

Volumn 55, Issue 9, 2015, Pages 2113-2122

  Bravo, Marjorie ^a   Shaz, Beth H ^b   Kamel, Hany ^a   Vanderpool, Sandra ^a   Tomasulo, Peter ^a   Custer, Brian ^c,d   Townsend, Mary ^a  

^a Blood Systems Incorporated   (United States)

^b NEW YORK BLOOD CENTER   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; APHERESIS DEVICE; ARTICLE; BACILLUS; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BLOOD TRANSFUSION REACTION; CORYNEBACTERIUM; DISINFECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; THROMBOCYTOPHERESIS; BACTERIUM; DEVICES; MEDICAL DEVICE CONTAMINATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES; RISK FACTOR; THROMBOCYTE;

BACTERIA; BACTERIOLOGICAL TECHNIQUES; BLOOD PLATELETS; DISINFECTION; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; MALE; PLATELETPHERESIS; RISK FACTORS;

EID: 84941804023     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13107     Document Type: Article

References (34)

1. Hansen A, Jurach J, Turner T, et al., The effect of processing method on the in vitro characteristics of red blood cell products. Vox Sang 2015 [Epub ahead of print]. DOI: 10.1111/vox.12233.
2. Hansen A, Turner T, Yi QL, et al., Quality of red blood cells washed using an automated cell processor with and without irradiation. Transfusion 2014; 54: 1585-94.
3. Vassallo R, Murphy S,. A critical comparison of platelet preparation methods. Curr Opin Hematol 2006; 13: 323-30.
4. Korte D, Marcelis J,. Platelet concentrates: reducing the risk of transfusion-transmitted bacterial infections. Int J Clin Trans Med 2014; 2: 29-37.
5. Pietersz R,. Pooled platelet concentrates: an alternative to single donor apheresis platelets. Transfus Apher Sci 2009; 41: 115-9.
6. Vamvakas E,. Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks. Transfusion 2009; 49: 2743-58.
7. Vamvakas E, Blajchman M,. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113: 3406-17.
8. Public Health of Canada. Transfusion Transmitted Injuries Surveillance System (TTISS): program report 2004-2005 [Internet]. Ottawa: Public Health of Canada; 2005 [cited 2015 3/19/2015]. Available from: http://publications.gc.ca/collections/collection-2008/phac-aspc/HP37-1-2005E.pdf
9. Eder A, Kennedy J, Dy B, et al., Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion 2009; 49: 1554-63.
10. Eder A, Kennedy J, Dy B, et al., Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007; 47: 1134-42.
11. Eder AF, Dy BA, Perez JM, et al., Comparable bacterial safety of platelets collected from single, double or triple apheresis procedures. Transfusion 2012; 52: 2.
12. Kleinman S, Kamel H, Harpool D, et al., Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets. Transfusion 2006; 46: 1787-94.
13. Souza S, Bravo M, Poulin T, et al., Improving the performance of culture-based bacterial screening by increasing the sample volume from 4 mL to 8 mL in aerobic culture bottles. Transfusion 2012; 52: 1576-82.
14. Su L, Kamel H, Custer B, et al., Bacterial detection in apheresis platelets: blood systems experience with a two-bottle and one-bottle culture system. Transfusion 2008; 48: 1842-52.
15. American Association of Blood Banks. Guidance on implementation of new bacteria and reduction standard. Bulletin 04-07. Bethesda: American Association of Blood Banks; 2004.
16. Benjamin R, Dy S, Perez A, et al., Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results. Vox Sang 2014; 106: 23-30.
17. Brecher M, Blajchman M, Yomtovian R, et al., Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future. Transfusion 2013; 53: 221-31.
18. Brecher M, Jacobs M, Katz L, et al., Survey of methods used to detect bacterial contamination of platelet products in the United States in 2011. Transfusion 2013; 53: 911-8.
19. Center for Biologics Evaluation & Research; Vaccines, Blood & Biologics. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2013. Silver Spring (MD): U.S. Food and Drug Administration; 2014 [cited 2015 Mar 19]. Available from: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm391574.htm
20. Jenkins C, Ramírez-Arcos S, Goldman M, et al., Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011; 51: 2555-65.
21. Palavecino E, Yomtovian R, Jacobs M,. Bacterial contamination of platelets. Transfus Apher Sci 2010; 42: 71-82.
22. Goldman M, Roy G, Fréchette N, et al., Evaluation of donor skin disinfection methods. Transfusion 1997; 37: 309-12.
23. Ramirez-Arcos S, Goldman M,. Skin disinfection methods: prospective evaluation and postimplementation results. Transfusion 2010; 50: 59-64.
24. de Korte D, Curvers J, de Kort W, et al., Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusion in the Netherlands. Transfusion 2006; 46: 476-85.
25. Benjamin R, Dy B, Warren R, et al., Skin disinfection with a single-step 2% chlorhexidine swab is more effective than a two-step povidone-iodine method in preventing bacterial contamination of apheresis platelets. Transfusion 2011; 51: 531-8.
26. Murphy W, Foley M, Doherty C,. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008; 95: 13-9.
27. Schmidt M, Sireis W, Seifried E,. Implementation of bacterial detection methods into blood donor screening-overview of different technologies. Transfus Med Hemother 2011; 38: 259-65.
28. Benjamin R, McDonald C,. The international experience of bacterial screen testing of platelet components with an automated microbial detection system: a need for consensus testing and reporting guidelines. Transfus Med Rev 2014; 28: 61-71.
29. Wagner S,. A model to predict the improvement in of automated blood culture detection by doubling platelet sample volume. Transfusion 2007; 47: 430-3.
30. Ezuki S, Kawabata K, Kanno T, et al., Culture-based bacterial detection systems for platelets: the effect of time prior to sampling and duration of incubation required for detection with aerobic culture. Transfusion 2007; 47: 2044-9.
31. McDonald C, Ball J, Allen J, et al., The first year of bacterial screening of platelet components-the English experience. Vox Sang 2012; 103 (Suppl 1): 176.
32. Ramírez-Arcos S, Jenkins C, Dion J, et al., Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007; 47: 421-9.
33. Tomasulo PA, Wagner SJ,. Predicting improvement in detection of bacteria in apheresis platelets by maintaining constant component sampling proportion. Transfusion 2013; 43: 835-42.
34. Pearce S, Rowe G, Field S,. Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus Med 2011; 21: 25-32.